Rasagiline is molecularly a propargylamine derivative.  The form brought to market by Teva and its partners is the mesylate salt, and was  designated chemically as: 1H-Inden-1-amine-2,3-dihydro-N-2-propynyl-(1R)-methanesulfonate.